FDA approves Novavax COVID-19 vaccine, but with unusual restrictions on its use
www.pbs.org
In its Friday approval letter, the FDA didn’t explain the restrictions although they reflect skepticism about vaccines from Health Secretary Robert F. Kennedy Jr. and other Trump officials.

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions.

Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency authorization from FDA for use in anyone 12 and older.

But late Friday, the FDA granted the company full approval for its vaccine for use only in adults 65 and older – or those 12 to 64 who have at least one health problem that puts them at increased risk from COVID-19.

Vaccines made by Novavax’s competitors Pfizer and Moderna already are fully licensed for use in anyone 12 and older, and also are authorized for use in children as young as 6 months.

  • MagicShel@lemmy.zipEnglish
    7·
    19 hours ago

    I’ve had Covid twice. The second one wasn’t bad because of the vaccine, but my lungs are still damaged five years later from my first bout with it—which wasn’t even particularly serious (never hospitalized or anything). I lost a bit of lung capacity and ever since I have had an awful barky cough and any chest congestion takes me weeks to clear.

    It’s a massive spectrum of severity.